Carmell Therapeutics Corp of PITTSBURGH, PA, a company, filed a Form D exempt-offering notice with the SEC on 2011-04-13. The offering totals $3.0M, of which $2.4M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| J. Michael Egan | Director | Pittsburgh, PA |
| James Michael Jordan | Director | Pittsburgh, PA |
| Paul Michael Kornblith | Director | Pittsburgh, PA |
| William Michael Newlin | Director | Sewickley, PA |
| Richard Michael Upton | Director | Keene, NH |
| Richard Upton | Director | Lowell, MA |
| David W Anderson | Director | Hingham, MA |
| James Hart | Executive Officer | San Francisco, CA |
| Donna Godward | Executive Officer | Pittsburgh, PA |
| Stephanie W Kladakis | Executive Officer | Pittsburgh, PA |
| Randolph Hubbell | Director | Pittsburgh, PA |
| Randolph Hubbell | Executive Officer | Pittsburgh, PA |
| Wendy W DiCicco | Director | Philadelphia, PA |
| James F Jordan | Director | Pittsburgh, PA |
| Alan I West | Director | Pittsburgh, PA |
| Alan I West | Executive Officer | Pittsburgh, PA |
| Paul I Kornblith | Director | Pittsburgh, PA |
| Paul I Kornblith | Executive Officer | Pittsburgh, PA |
| William I Newlin | Director | Sewickley, PA |
| William I Newlin | Executive Officer | Sewickley, PA |
| James I Jordan | Director | Pittsburgh, PA |
| Richard I Upton | Director | Keene, NH |
Showing 15 of 18 filings.
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2020-09-25 | D/A | $3.5M | $2.4M |
| 2020-07-08 | D | $50K | $50K |
| 2019-10-16 | D | $2.3M | $80K |
| 2019-03-14 | D/A | $7.5M | $5.2M |
| 2018-07-13 | D | $4.5M | $1.1M |
| 2018-04-25 | D/A | $6.0M | $439K |
| 2018-01-10 | D | $6.0M | $364K |
| 2017-12-06 | D/A | $2.0M | $2.0M |
| 2017-10-03 | D | $1.5M | $398K |
| 2017-04-14 | D/A | $2.0M | $1.1M |
| 2017-01-09 | D | $1.5M | $767K |
| 2016-02-05 | D | $1.0M | $775K |
| 2015-08-04 | D | $300K | $137K |
| 2014-12-30 | D/A | $556K | $556K |
| 2014-11-12 | D | $500K | $304K |